Market Overview – February 04, 2026
📊 Market Indices
- 📉 S&P 500: 6,882.73 (-35.08 / (-0.51%))
- 📉 Nasdaq: 22,920.12 (-335.07 / (-1.44%))
- 📈 Dow Jones: 49,501.30 (+260.31 / (+0.53%))
🎯 5 Focus Points for Tomorrow
- Semiconductor recovery attempt – watching AMD, MU for stabilization
- February 11 delayed jobs report – critical for Fed policy expectations
- China trade signals – soybean purchases hinting at broader thaw
- Treasury yields – testing resistance as 10-year approaches 4.30%
- Tech rotation dynamics – Nasdaq/Dow divergence sustainability
Closing Bell
The S&P 500 found itself stuck in the middle of this market tug-of-war, sliding 0.51% to 6,882.73 as tech’s weight dragged it lower. Bitcoin joined the risk-off party, tumbling 4.48% to $73,340, while Treasury yields ticked higher across the curve—the 10-year adding 3 basis points to 4.28%. The dollar flexed its muscles too, climbing to 97.67 on the DXY index.
Trading volume tilted heavily bearish in semiconductors, with the AI chip narrative taking a breather after months of relentless gains. Investors rotated into defensive positions and value plays, suggesting growing caution about stretched tech valuations heading into next week’s delayed jobs report.
Market Drivers
Automakers caught a bid on policy hopes too, with Ford (F) and GM (GM) expressing support for Trump’s plan to ease fuel economy standards despite requesting modifications. The timing’s interesting since Ford just reported a 5.3% drop in January U.S. sales to 135,362 vehicles, with sluggish EV demand continuing to plague the transition narrative. The aerospace sector also grabbed attention as SAS negotiates widebody orders with Boeing (BA) and Airbus (EADSF, EADSY), anticipating stronger long-haul travel demand.
Retail and healthcare delivered their own drama. Target’s (TGT) new CEO Michael Fiddelke admitted the company has lost trust with both customers and employees—a refreshingly honest assessment that the stock market won’t forgive easily. Meanwhile, Abbott (ABT) issued a recall for glucose monitoring sensors linked to seven deaths and 860 serious injuries, reminding investors that healthcare isn’t just about innovation but also about getting the basics right. Cigna (CI) settled with the FTC over insulin pricing practices, agreeing to revamp its drug pricing approach.
Investor Pulse
There’s a palpable sense that investors are recalibrating expectations around AI chip demand and wondering if we’ve gotten ahead of ourselves. Cerebras Systems raising $1 billion at a $23 billion valuation shows capital still flows to AI infrastructure, but public market investors are growing more selective. The outperformance in bright spots like Enphase Energy (ENPH), up 28%, and Silicon Labs (SLAB), soaring 33%, suggests specific stock-picking is rewarding deeper analysis over index-hugging.
The delayed January jobs report—now scheduled for February 11 after shutdown-related postponements—hangs over sentiment like a question mark. Without fresh employment data, traders are flying partially blind on the economy’s trajectory, which might explain the defensive rotation into Dow components and away from high-beta tech names.
Final Thoughts
Next week’s jobs report on February 11 becomes the critical datapoint that could either validate the tech selloff or spark a violent reversal. If employment remains robust, it justifies higher yields and continued pressure on long-duration growth stocks. If it disappoints, suddenly those beaten-down chip names start looking attractive again at lower valuations.
For now, the message is clear: diversification matters, and concentration risk in mega-cap tech can bite hard on days like today. Watch how semiconductor stocks trade in the coming sessions—if AMD and Micron find support and bounce, it was just a healthy correction. If they keep sliding, we might be in for a more significant rotation that favors the Dow’s old-guard constituents over Silicon Valley’s darlings. The February 11 jobs data will likely be the tiebreaker.
This newsletter was generated by the Stock Focus Report team.
